Assist Prof. Dr. Madhu Biyani, Kanazawa University, Japan
Dr. Madhu Biyani is a physician and bioengineer from India, currently serving as Assistant Professor at NanoLSI, Kanazawa University, Japan. With a doctorate in bioengineering from Saitama University, her expertise lies in drug metabolism and electrochemical biosensors. She bridges clinical insight with molecular biology, contributing to research on peptide aptamers for targeted diagnostics. Her interdisciplinary work enriches biomedical innovation, especially in precision medicine. Fluent in Japanese and English, Dr. Biyani’s global academic and research journey exemplifies scientific excellence and cross-cultural collaboration. 🌏
👩⚕️ Profile
Scopus
🎓 Education
Dr. Biyani completed her Bachelor of Homoeopathic Medicine and Surgery (B.H.M.S.) from the University of Rajasthan in 2000. She then pursued her Ph.D. in Bioengineering at Saitama University, Japan, in 2011. Her doctoral thesis focused on enhancing protease activity using peptide aptamers for drug discovery applications. She also holds JLPT Level N3 certification, demonstrating proficiency in Japanese. Her educational path reflects a strong integration of clinical medicine and molecular engineering—forming the basis of her impactful biosensor and drug metabolism research. 🎓
💼 Experience
Dr. Biyani has over 15 years of experience in biomedical research across academia and industry. She has worked in premier Japanese projects such as REDS (JST), City Area, and Sentan, focusing on biomolecule design and diagnostics. Her tenure includes research roles in Saitama University, JAIST, and Toyama Prefectural University. She also contributed to a private biotech firm, BioDevice Technology Ltd. Since 2020, she’s held a faculty position at NanoLSI, where she leads drug metabolism and toxicology studies. Her career reflects a diverse, well-rounded scientific journey from bench to bedside. 🔬
🔬 Research Interest
Dr. Biyani’s research focuses on drug metabolism, toxicology, peptide aptamer development, and electrochemical biosensors. She is passionate about translating molecular tools into clinically actionable platforms, enabling real-time monitoring of enzymatic activity and drug responses. Her work integrates nanotechnology, molecular biology, and analytical chemistry—providing precision tools for early disease detection and safer drug therapies. She is particularly interested in using biosensors for evaluating liver enzyme functions and metabolic pathways, which can revolutionize personalized medicine. ⚗️
🏅 Awards
While Dr. Biyani has not yet received high-profile awards, she is an emerging talent with significant contributions to Japanese and international biomedical research. Her involvement in multiple Japanese Science and Technology Agency (JST) projects and her role in developing clinical biosensing platforms position her as a strong contender for research recognition. Her cross-disciplinary and multicultural profile makes her an ideal candidate for young researcher, women in science, and bioengineering innovation awards. 🌟
📚 Publication Top Notes
“Protease Activity-Enhancing Peptide Aptamer Development”
“Application of Electrochemical Biosensors in Drug Toxicity Screening”
“Design of Aptamer-Based Platforms for Drug Metabolism Analysis”